Normal view MARC view ISBD view

Clinical Consensus Statement: Vaginal Energy-Based Devices.

MedStar author(s):

Citation: Urogynecology (Hagerstown, Md.). 28(10):633-648, 2022 Oct 01.PMID: 36256959Institution: MedStar Washington Hospital CenterDepartment: Obstetrics and Gynecology/Female Pelvic Medicine and Reconstructive SurgeryForm of publication: Journal ArticleMedline article type(s): Journal ArticleSubject headings: IN PROCESS -- NOT YET INDEXEDYear: 2022 ISSN:

2771-1897

Name of journal: Urogynecology (Hagerstown, Md.)Abstract: ABSTRACT: This clinical consensus statement on vaginal energy-based devices (EBDs) reflects an update by content experts from the American Urogynecologic Society's EBD writing group. In 2019, the American Urogynecologic Society's EBD writing group used a modified Delphi process to assess statements that were evaluated for consensus after a structured literature search. A total of 40 statements were assessed and divided into 5 categories: (1) patient criteria, (2) health care provider criteria, (3) efficacy, (4) safety, and (5) treatment considerations. Of the 40 statements that were assessed, 28 reached consensus and the remaining 12 did not. Lack of evidence was among the main reasons that vulvovaginal EBD treatment statements did not reach consensus. In March 2022, these statements were reassessed using the interim literature. Copyright © 2022 American Urogynecologic Society. All rights reserved.All authors: Alshiek J, Clark A, Garcia B, Iglesia CB, Kimble A, Malik SA, Minassian V, Murphy M, Shobeiri SA, Sokol ERFiscal year: FY2023 Digital Object Identifier:

https://dx.doi.org/10.1097/SPV.0000000000001241

Date added to catalog: 2022-10-27

Holdings ( 1 )
Title notes ( 2 )

Holdings
Item type	Current library	Collection	Call number	Status	Date due	Barcode
Journal Article	MedStar Authors Catalog	Article	36256959	Available		36256959

ABSTRACT: This clinical consensus statement on vaginal energy-based devices (EBDs) reflects an update by content experts from the American Urogynecologic Society's EBD writing group. In 2019, the American Urogynecologic Society's EBD writing group used a modified Delphi process to assess statements that were evaluated for consensus after a structured literature search. A total of 40 statements were assessed and divided into 5 categories: (1) patient criteria, (2) health care provider criteria, (3) efficacy, (4) safety, and (5) treatment considerations. Of the 40 statements that were assessed, 28 reached consensus and the remaining 12 did not. Lack of evidence was among the main reasons that vulvovaginal EBD treatment statements did not reach consensus. In March 2022, these statements were reassessed using the interim literature. Copyright © 2022 American Urogynecologic Society. All rights reserved.

English